- Home
- Publications
- Publication Search
- Publication Details
Title
E2F1 inhibition mediates cell death of metastatic melanoma
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 5, Pages -
Publisher
Springer Nature
Online
2018-05-09
DOI
10.1038/s41419-018-0566-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma
- (2017) Paola Falletta et al. GENES & DEVELOPMENT
- Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance
- (2016) Michaël Cerezo et al. CANCER CELL
- Metastatic Melanoma: Insights Into the Evolution of the Treatments and Future Challenges
- (2016) Antoine Millet et al. MEDICINAL RESEARCH REVIEWS
- Mechanism of melanoma cells selective apoptosis induced by a photoactive NADPH analogue
- (2016) Florian Rouaud et al. Oncotarget
- Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma
- (2015) Christian Posch et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Increased CD271 expression by the NF-kB pathway promotes melanoma cell survival and drives acquired resistance to BRAF inhibitor vemurafenib
- (2015) Abdelali Lehraiki et al. Cell Discovery
- Mitochondrial oxidative stress is the achille’s heel of melanoma cells resistant to Braf-mutant inhibitor
- (2015) Paola Corazao-Rozas et al. Oncotarget
- Inhibition of Melanogenesis by the Antidiabetic Metformin
- (2014) Abdelali Lehraiki et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Vemurafenib Synergizes with Nutlin-3 to Deplete Survivin and Suppresses Melanoma Viability and Tumor Growth
- (2013) Z. Ji et al. CLINICAL CANCER RESEARCH
- CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
- (2013) P. A. Ott et al. CLINICAL CANCER RESEARCH
- Cutaneous melanoma
- (2013) Alexander MM Eggermont et al. LANCET
- Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
- (2013) M. Cerezo et al. MOLECULAR CANCER THERAPEUTICS
- Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
- (2013) Meghna Das Thakur et al. NATURE
- The Dark Side of E2F1: In Transit beyond Apoptosis
- (2012) D. Engelmann et al. CANCER RESEARCH
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6
- (2012) Sameer Phalke et al. NUCLEIC ACIDS RESEARCH
- Cell cycle regulators in the control of metabolism
- (2011) Emilie Blanchet et al. CELL CYCLE
- E2F1-dependent oncogenic addiction of melanoma cells to MDM2
- (2011) M Verhaegen et al. ONCOGENE
- Microphthalmia-Associated Transcription Factor Controls the DNA Damage Response and a Lineage-Specific Senescence Program in Melanomas
- (2010) Sandy Giuliano et al. CANCER RESEARCH
- Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth
- (2010) T Botton et al. CELL DEATH AND DIFFERENTIATION
- Feedback between p21 and reactive oxygen production is necessary for cell senescence
- (2010) João F Passos et al. Molecular Systems Biology
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- In Vitro and In Vivo Anti-Melanoma Effects of Ciglitazone
- (2009) Thomas Botton et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- E2F1 in Melanoma Progression and Metastasis
- (2009) Vijay Alla et al. JNCI-Journal of the National Cancer Institute
- Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival
- (2009) D. Bogunovic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Small-Molecule E2F Inhibitor Blocks Growth in a Melanoma Culture Model
- (2008) Y. Ma et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now